Pre-Announcement: 2025 Joint Transnational Call for Proposals on Rare Disease Therapies ERDERA
what
Pre-Announcement of 2025 Joint Transnational Call for Proposals on Rare Disease Therapies
The European Rare Diseases Research Alliance (ERDERA) is excited to announce the upcoming launch of its Joint Transnational Call (JTC) for Proposals 2025. Set to officially open on December 10, 2024, this call will invite research teams from across Europe and beyond to submit collaborative projects focused on “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation”.
This JTC will build upon the significant progress made by previous European Joint Programme on Rare Diseases (EJP RD) calls, with the aim of fostering international partnerships to develop innovative therapies for rare diseases.
Who
Researchers, SMEs and all stakeholders from public and private research institutions in Health
When
10 December 2024
Further information
Aim of the Call
The primary objective is to support interdisciplinary, transnational collaborations that leverage complementary expertise to develop new therapies for rare diseases. Research projects should focus on pre-clinical studies involving small molecules or biologicals. This could include the development of novel therapies, biomarkers for therapy efficiency, or replication of pre-clinical studies to validate findings.
Please note that this is a draft announcement and the list of funders is not final.
Topics of Interest
Eligible proposals may include research on:
- Development of pre-clinical therapies using cell, organoid, or animal models.
- Biomarker identification that correlates with therapeutic efficacy.
- Pre-clinical proof-of-concept studies showing pharmacological activity and safety data.
Application deadline: 13.2.25, pre-proposal deadline. 9.7.25, full proposal submission deadline. For more information, click on the link